Items where authors include "Langley, R.E."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 6.

Article

Grosser, B., Emmerson, J. orcid.org/0000-0002-8198-8043, Reitsam, N.G. orcid.org/0000-0002-0070-3158 et al. (7 more authors) (2024) Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British Journal of Cancer, 130 (3). pp. 457-466. ISSN 0007-0920

Beuque, M., Magee, D.R. orcid.org/0000-0003-2170-3103, Chatterjee, A. et al. (7 more authors) (2023) Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides. Journal of Pathology Informatics, 14. 100192. ISSN 2229-5089

Parker, C.C., James, N.D. orcid.org/0000-0002-7314-8204, Brawley, C.D. orcid.org/0000-0003-3641-278X et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Clarke, N.W., Ali, A., Ingleby, F.C. et al. (47 more authors) (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer : long-term survival results from the STAMPEDE trial. Annals of Oncology. 396. pp. 1-12. ISSN 0923-7534

Cunningham, D., Stenning, S.P., Smyth, E.C. et al. (15 more authors) (2017) Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. The Lancet Oncology, 18 (3). pp. 357-370. ISSN 1470-2045

Mulvenna, P., Nankivell, M., Barton, R. et al. (16 more authors) (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. The Lancet, 388 (10055). pp. 2004-2014. ISSN 0140-6736

This list was generated on Sun Apr 21 02:48:04 2024 BST.